Our Latest News and Events

Annual General Meeting 2018

.

Join us on the 4th October 2018 for our Annual General Meeting | Everyone is welcome!

Venue: Knowledge Hub, Gate C, The Royal Orthopaedic Hospital NHS Foundation Trust, B31 2AP

Time: 4pm - 5pm Networking, NHS 70th Bake sale & Interactive Stalls, 5pm - 7pm Annual General Meeting

We will be reflecting on how The Royal Orthopaedic Hospital has performed over the last year, celebrate successes, our pioneering plans for the future and to present our annual report & accounts.

This is a great opportunity to network with our community, find out all about the life changing work we provide, and to get your views heard.

There will be stalls displaying this years work, as well as an NHS 70th Charity Bake sale celebrating 70 years of excellent care!

We will be able to provide an electronic version (or paper copy) of the Annual Report and Accounts on request.

There will be free parking on site, however this may be limited.

Click here to register to attend

For more information call 01216854379 or email This email address is being protected from spambots. You need JavaScript enabled to view it./

Notice of Public Board Meeting on Wednesday 5 September 2018

.

Notice of Public Board Meeting on Wednesday 5 September 2018

The next meeting in public of the Royal Orthopaedic Hospital NHS Foundation Trust NHS Trust Board will take place on Wednesday 5 September 2018 commencing at 1100h in the Board Room at the Royal Orthopaedic Hospital NHS Foundation Trust Headquarters.

         

Members of the public and press are welcome to attend. The agenda for the public part of the meeting is available on the website.

Questions for the Board should be received by the Trust Board Administrator no later than 24hrs prior to the meeting by post or e-mail to: Trust Board Administrator, Claire Kettle at the Management Offices or via email This email address is being protected from spambots. You need JavaScript enabled to view it.

Dame Yve Buckland

Chairman

Public Bodies (Admissions to Meetings) Act 1960

Members of the Public and Press are entitled to attend these meetings although the Trust Board reserves the right to exclude, by Resolution, the Press and Public wherever publicity would be prejudicial to the public interest by reason of the confidential nature of the business to be transacted or for other special reasons, stated in the Resolution

Governor Drop in Sessions – You're Invited!

.

Governor Drop in Sessions – You're Invited!

Date: Monday 6th August 2018

Time: 12 – 2pm

Venue: Outpatients Reception

Governors attending: Mr Brian Toner (lead governor) & Mr Petro Nicolaides (public governor)

Our Governors represent the interests of the hospital’s local constituencies, which is why we are taking active measures to ensure our community have appropriate access to our governors.

We invite our local community, Birmingham residents, to attend our governor drop-in session next week as an opportunity to share their views, as well as find out more about foundation trust membership opportunities & the role of a governor.

All our patients, public & members will also be encouraged to give informal feedback about their recent experiences of care and any ideas for future, which Brian & Petro will feedback to the Council of Governors & Trust Chairman, Yve Buckland.

To find out more about our council of governors, visit

https://www.roh.nhs.uk/about-us/our-team/category/governors

For more information about this session, please call Elaine Chapman – Membership Officer on 0121 685 4379 or email This email address is being protected from spambots. You need JavaScript enabled to view it.

Notice of Public Board Meeting on Wednesday 6 June 2018

.

Notice of Public Board Meeting on Wednesday 6 June 2018

The next meeting in public of the Royal Orthopaedic Hospital NHS Foundation Trust NHS Trust Board will take place on Wednesday 6 June 2018 commencing at 1145h in the Board Room at the Royal Orthopaedic Hospital NHS Foundation Trust Headquarters.

         

Members of the public and press are welcome to attend. The agenda for the public part of the meeting is available on the website.

Questions for the Board should be received by the Trust Board Administrator no later than 24hrs prior to the meeting by post or e-mail to: Trust Board Administrator, Claire Kettle at the Management Offices or via email This email address is being protected from spambots. You need JavaScript enabled to view it.

Dame Yve Buckland

Chairman

Public Bodies (Admissions to Meetings) Act 1960

Members of the Public and Press are entitled to attend these meetings although the Trust Board reserves the right to exclude, by Resolution, the Press and Public wherever publicity would be prejudicial to the public interest by reason of the confidential nature of the business to be transacted or for other special reasons, stated in the Resolution

ROH leads the way with innovative knee therapy

.

Spherox, a new therapy that could help people across the UK currently living with knee pain, is now available on the NHS.

 
Today, for the first time in the UK, a patient will undergo an operation using his own cells to repair defective cartilage in his knee at The Royal Orthopaedic Hospital (ROH) in Birmingham. The personalised therapy, called Spherox, has been shown to significantly reduce pain and improve quality of life in patients with cartilage defects, and is now available to eligible patients on the NHS.
 
The 30 year old patient, Dan McKenzie, injured his knee six years ago, when he was training to be a football coach. A year after the initial injury, Dan’s doctors found that not only had he torn the ligaments in his knee, but he had also caused significant damage to the cartilage (cushioning) in the joint.
 
“I’ve been living with this pain for six years now. While there are some days that I find the pain manageable, there are other days that the pain is so terrible that I can’t climb the stairs,” said Dan. “I feel lucky to be able to try this new therapy under the care of leading specialists at The ROH. I’m hopeful that this new therapy will help me get back into sport – and perhaps also playing football again one day.”
 
dan
Image courtesy of BBC MIdlands Today
 
Cartilage found in knee joints acts as a shock absorber and can be worn away through trauma, repetitive injury or “wear and tear”. As this happens the bones begin to grate against each other resulting in difficulty moving and joint stiffness. It is estimated that every year in the UK, around 10,000 people have knee cartilage damage serious enough to require treatment. While smaller injuries can be treated successfully with other methods, those with mid- to larger injuries to their cartilage would benefit from this novel treatment.
 
Spherox, developed by German-based company CO.DON, is a personalised treatment that is developed using a sample of healthy cartilage cells from a patient’s own knee. The cells are then grown in a laboratory using CO.DON’s innovative biological techniques, condensing the healthy cells into spheroids (spherical balls). In this first UK operation, key-hole surgery will be used to re-implant these spheroids back into the patient’s knee where the healthy cartilage will use them as building blocks to repair itself naturally.

“There are limited options available on the NHS for managing cartilage defects larger than 2cm2, so we are very pleased to have this new treatment option and to be the first hospital in the UK to use it,” said Professor Martyn Snow, Consultant Orthopaedic Surgeon at The ROH in Birmingham. “Now that it is more accessible, we look forward to being able to help more patients who qualify for the treatment.”


About the Spherox treatment

Spherox has been widely used in Germany for cartilage defects of larger than 2cm. After completion of rehabilitation, Spherox offers 88% improvement of activities of daily living,3 which include walking up and down stairs, getting in and out of a car, or walking on a flat surface. Without treatment, cartilage injuries of this size can go on to cause greater cost to both the patients’ QoL and to the NHS, as the joint may develop arthritis or progress to complete loss of cartilage requiring a knee replacement. The National Institute for Health and Care Excellence (NICE), the UK body responsible for recommending cost-effective medicine, have determined that at £14,845 per operation, Spherox is to be available on the NHS to eligible patients with cartilage defects of up to 10cm2 in size.

Notice of Public Board Meeting on Wednesday 2 May 2018

.

The next meeting in public of the Royal Orthopaedic Hospital NHS Foundation Trust NHS Trust Board will take place on Wednesday 2 May 2018 commencing at 1030h in the Board Room at the Royal Orthopaedic Hospital NHS Foundation Trust Headquarters.

Members of the public and press are welcome to attend. The agenda for the public part of the meeting is available on the website.

Questions for the Board should be received by the Trust Board Administrator no later than 24hrs prior to the meeting by post or e-mail to: Trust Board Administrator, Claire Kettle at the Management Offices or via email This email address is being protected from spambots. You need JavaScript enabled to view it.

Dame Yve Buckland

Chairman

Public Bodies (Admissions to Meetings) Act 1960

Members of the Public and Press are entitled to attend these meetings although the Trust Board reserves the right to exclude, by Resolution, the Press and Public wherever publicity would be prejudicial to the public interest by reason of the confidential nature of the business to be transacted or for other special reasons, stated in the Resolution